Equities

Charmacy Pharmaceutical Co Ltd

Charmacy Pharmaceutical Co Ltd

Actions
Consumer Staples Personal Care, Drug and Grocery Stores
  • Price (HKD)9.80
  • Today's Change0.50 / 5.38%
  • Shares traded7.00k
  • 1 Year change-24.62%
  • Beta0.0289
Data delayed at least 15 minutes, as of Nov 15 2024 07:44 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Balance sheet Back to Overview

In millions of CNY
(except for per share items)
Fiscal data as of Dec 31 2023202320222021
ASSETS
Cash And Short Term Investments634493630
Total Receivables, Net1,019994786
Total Inventory776587509
Prepaid expenses383388312
Other current assets, total0.500.630.36
Total current assets2,8122,4622,238
Property, plant & equipment, net329294348
Goodwill, net6.026.026.02
Intangibles, net7781143
Long term investments------
Note receivable - long term------
Other long term assets------
Total assets3,2482,8662,763
LIABILITIES
Accounts payable659633533
Accrued expenses538049
Notes payable/short-term debt588513668
Current portion long-term debt/capital leases6.594.1535
Other current liabilities, total1,3131,025874
Total current liabilities2,6192,2562,159
Total long term debt301699
Total debt625533802
Deferred income tax0.600.060.40
Minority interest------
Other liabilities, total----0.30
Total liabilities2,6502,2712,259
SHAREHOLDERS EQUITY
Common stock108108108
Additional paid-in capital------
Retained earnings (accumulated deficit)490487396
Treasury stock - common------
Unrealized gain (loss)------
Other equity, total------
Total equity598595504
Total liabilities & shareholders' equity3,2482,8662,763
Total common shares outstanding108108108
Treasury shares - common primary issue000
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.